Login

AVANOS MEDICAL, INC. SEC Filings

Filed On Filing
06 Aug 2026 FORM 15-12G
31 Jul 2026 FORM S-8 POS
31 Jul 2026 SCHEDULE 13G
30 Jul 2026 8-K: Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement +8 more

as Revolving Administrative Agent, the Swingline Lender and an L/C Issuer

28 Jul 2026 Form 4: Delgado Sigfrido, SVP, Operations

Returned 110,627 shares to the issuer ($2.77M) · Received 54,886 shares as a grant or award · Disposed of 59,434 Employee Stock Option (right to buy) (Disposition to Issuer)

28 Jul 2026 Form 4: Galovan Scott Michael, SVP, Chief Financial Officer

Returned 231,717 shares to the issuer ($5.79M) · Received 96,121 shares as a grant or award · Disposed of 90,668 Employee Stock Option (right to buy) (Disposition to Issuer)

28 Jul 2026 Form 4: Pacitti David, Chief Executive Officer

Returned 766,924 shares to the issuer ($19.2M) · Received 444,730 shares as a grant or award · Disposed of 239,354 Employee Stock Option (right to buy) (Disposition to Issuer)

28 Jul 2026 Form 4: Shimer Julie Ann, Director

Returned 50,090 shares to the issuer ($1.25M) · Disposed of 12,003 Restricted Share Units (Disposition to Issuer) ($300K)

28 Jul 2026 Form 4: Oleary Patrick J, Director

Returned 54,640 shares to the issuer ($1.37M) · Disposed of 12,003 Restricted Share Units (Disposition to Issuer) ($300K)

28 Jul 2026 Form 4: Franchini Indrani Lall, Director

Returned 4,817 shares to the issuer ($120K) · Disposed of 12,003 Restricted Share Units (Disposition to Issuer) ($300K)

28 Jul 2026 Form 4: Egbuonu-Davis Lisa, Director

Returned 13,811 shares to the issuer ($345K) · Disposed of 12,003 Restricted Share Units (Disposition to Issuer) ($300K)

28 Jul 2026 Form 4: Blackford Gary, Director

Returned 119,590 shares to the issuer ($2.99M) · Disposed of 12,003 Restricted Share Units (Disposition to Issuer) ($300K)

27 Jul 2026 25-NSE
22 Jul 2026 8-K: Submission of Matters to a Vote of Security Holders; Regulation FD Disclosure

ALPHARETTA, GA – July 22, 2026 – Avanos Medical, Inc. (NYSE: AVNS) (“Avanos” or the “Company”), a leading medical technology company, today announced that its stockholders have voted to approve the pending acquisition of Avanos by affili...

15 Jul 2026 DEFA14A
15 Jul 2026 8-K: Other Events

As previously disclosed, on April 13, 2026, Avanos Medical, Inc. (“Avanos” or the “Company”) entered into an Agreement and Plan of Merger (as it has been or may be amended, supplemented, waived or otherwise modified in accordance with it...

02 Jul 2026 DEFA14A
02 Jul 2026 8-K: Regulation FD Disclosure

ALPHARETTA, GA and NEW YORK, NY – July 2, 2026/PRNewswire/ – Avanos Medical, Inc. (NYSE: AVNS) (“Avanos”) and American Industrial Partners (“AIP”) jointly announced the receipt of all required regulatory approvals to complete the pending...

10 Jun 2026 DEFM14A
01 Jun 2026 FORM SD

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support